companion diagnostics

Compsit3 is an early-stage molecular imaging company focused on the development and commercialization of molecular imaging probes for the non-invasive detection of tissue inflammation. Its lead technology is CS-31, an imaging probe that targets and illuminates C3d deposited in tissues, a marker of immune activation, intended as a safer alternative to tissue biopsy for assessing disease activity and therapeutic response to complement inhibitors and other immune modulators.

Read more

development and commercialization of imaging probesmolecular imaging

EValuate Diagnostics is working to facilitate the detection of disease, with an emphasis on cancers, by establishing the least invasive testing methods with the greatest accuracy. The company harnesses circulating extracellular vesicles to detect circulating tumor biomarkers early, developing a novel non-invasive method of surveillance. It was created as the first spin-off company of Hackensack Meridian Health Research Institute.

Read more

circulating tumor biomarker detectionearly non-invasive disease detectionextracellular vesicle purification and isolationin vitro diagnosticsresearch services